SUCCESSFUL TREATMENT OF DISSEMINATED STRONGYLOIDIASIS

被引:20
作者
COULTER, C
WALKER, DG
GUNSBERG, M
BROWN, IG
BLIGH, JF
PROCIV, P
机构
[1] ROYAL BRISBANE HOSP,HERSTON,QLD 4006,AUSTRALIA
[2] UNIV QUEENSLAND,DEPT PARASITOL,ST LUCIA,QLD 4072,AUSTRALIA
关键词
D O I
10.5694/j.1326-5377.1992.tb137191.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To report the successful treatment of Strongyloides stercoralis hyperinfection, which is usually lethal but in this case was diagnosed in its early stages. Clinical features: A 44-year-old woman, who had spent much of her life in Fiji and india, was treated with a high dose of prednisolone for rheumatoid arthritis complicated by gold lung. The onset of abdominal symptoms, an exacerbation of respiratory symptoms, and a persistent high eosinophil count and serum IgE level, led to the detection of numerous Strongyloides larvae in her faeces and sputum. Intervention and outcome: She was treated with thiabendazole for five days, then mebendazole for one month, and the dose of prednisolone was reduced. Clinical symptoms and signs improved within days and after one week parasites could not be found in her faeces. After six months, enzyme-linked immunosorbent assay for Strongyloides infection gave a reading which was 40% of the initial level but still in the positive range. Conclusion: Steroid therapy in individuals with chronic, subclinical strongyloidiasis predisposes to the insidious development of hyperinfection syndrome, which has a high mortality rate. If detected early, this complication can be treated effectively. It can be prevented by actively seeking Strongyloides infection, by faecal microscopy and culture techniques and by serological tests, in high-risk individuals, such as immigrants from endemic areas.
引用
收藏
页码:331 / 332
页数:2
相关论文
共 50 条
  • [21] Delayed diagnosis of disseminated strongyloidiasis
    Hughes, P
    McGuire, G
    INTENSIVE CARE MEDICINE, 2001, 27 (01) : 310 - 312
  • [22] Delayed diagnosis of disseminated strongyloidiasis
    Richard Hughes
    Glenn McGuire
    Intensive Care Medicine, 2001, 27 : 310 - 312
  • [23] DISSEMINATED STRONGYLOIDIASIS - DETECTABLE AND PREVENTABLE
    KATZ, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (01): : 68 - 68
  • [24] Disseminated strongyloidiasis: A challenging diagnosis
    Studart, M.
    Quintella, D.
    Cuzzi, T.
    VIRCHOWS ARCHIV, 2016, 469 : S300 - S300
  • [25] Gastroduodenal involvement in disseminated strongyloidiasis
    Minamide, Tatsunori
    Fukushima, Masashi
    Inokuma, Tetsurou
    JGH OPEN, 2018, 2 (02): : 75 - 76
  • [26] Disseminated Strongyloidiasis in a Immunocompromised Host
    Mundkur, Suneel C.
    Aroor, Shrikiran
    Jayashree, K.
    INDIAN PEDIATRICS, 2011, 48 (12) : 974 - 976
  • [27] Disseminated strongyloidiasis in nephrotic syndrome
    Morimoto, J
    Kaneoka, H
    Sasatomi, Y
    Sato, YN
    Murata, T
    Ogahara, S
    Sakata, N
    Takebayashi, S
    Naito, S
    Saito, T
    CLINICAL NEPHROLOGY, 2002, 57 (05) : 398 - 401
  • [28] Disseminated strongyloidiasis in an AIDS patient
    Daniela Vaustat, Claudia
    Javier Bava, Amadeo
    ACTA BIOQUIMICA CLINICA LATINOAMERICANA, 2012, 46 (03): : 419 - 422
  • [29] Case Report: Non-Oral Treatment with Ivermectin for Disseminated Strongyloidiasis
    Fusco, Dahlene N.
    Downs, Jennifer A.
    Satlin, Michael J.
    Pahuja, Meera
    Ramos, Liz
    Barie, Philip S.
    Fleckenstein, Lawrence
    Murray, Henry W.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 83 (04) : 879 - 883
  • [30] Disseminated Strongyloidiasis: Breaking Brain Barriers
    Sebastian, Ivy Anne
    Pandian, Jeyaraj Durai
    Oberoi, Aroma
    Kate, Mahesh Pundlik
    Jaison, Vineeth
    Bose, Smriti
    Sahonta, Rajeshwar
    Nagpal, Shavi
    Brar, Indira
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2019, 22 (02) : 234 - +